NEVIRAPINE (NVP), 50mg, disp. tab.
STD
DORANEVI5TD
Valid Article
HS Code:
300490
Last Updated on:
22/10/2024, 13:10:58
Former
Code(s):
-X
6.4.2.2 - Non-nucleoside reverse transcriptase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AG01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
NEVIRAPINE (NVP)
Therapeutic Action
Antiretroviral, non-nucleoside reverse transcriptase inhibitor (NNRTI)
Indications
Neonatal ARV prophylaxis of mother-to-child transmission (PMTCT) in high-risk HIV-exposed neonates from 6 weeks of age.
Nevirapine is no longer part of the preferred treatment regimens for HIV infection.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
The choice between the oral suspension and the dispersible tablet will depend on the availability when ordering.
The tablet is to be dispersed in about 5 ml of water immediately before administration.
Storage
- Below 25ºC
- After opening, the oral suspension keeps for 2 months maximum.